The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of short-chain fatty acid (SCFA) and circulating cytokine trends in a clinical trial of nivolumab/ipilimumab and CBM588 in metastatic renal cell carcinoma (mRCC).
 
Nazli Dizman
Consulting or Advisory Role - Vivreon Biosciences
 
Khyatiben Pathak
No Relationships to Disclose
 
Marice Alcantara
No Relationships to Disclose
 
Luis A Meza
Honoraria - Ipsen
Travel, Accommodations, Expenses - Ipsen; Ipsen
 
Paulo Gustavo Bergerot
No Relationships to Disclose
 
Maya Willey
No Relationships to Disclose
 
Tanya B. Dorff
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bayer; Exelixis; Janssen Oncology; Pfizer; Sanofi/Aventis; Seagen
Research Funding - Pfizer (Inst)
 
Joann Hsu
No Relationships to Disclose
 
Zeynep Busra Zengin
No Relationships to Disclose
 
Daniela V. Castro
No Relationships to Disclose
 
Hedyeh Ebrahimi
No Relationships to Disclose
 
Alex Chehrazi-Raffle
Honoraria - OncLive/MJH Life Sciences
 
Abhishek Tripathi
Honoraria - Cardinal Health; Targeted Oncology; Urology times
Consulting or Advisory Role - AADi; Deka Biosciences; EMD Serono; Exelixis; Exelixis; Foundation Medicine; Genzyme; Pfizer; Seagen; Seattle Genetics/Astellas; Seattle Genetics/Astellas
Research Funding - Aravive (Inst); Bayer (Inst); Clovis Oncology (Inst); Corvus Pharmaceuticals (Inst); EMD Serono (Inst); Exact Sciences (Inst); Exelixis (Inst); Pfizer (Inst); WindMIL (Inst)
 
Jeffrey M. Trent
No Relationships to Disclose
 
Motomichi Takahashi
Leadership - Miyarisan pharmaceutical
 
Kentaro Oka
Employment - Miyarisan pharmaceutical
 
Seiya Higashi
Employment - Miyarisan pharmaceutical
 
Marcin Kortylewski
Stock and Other Ownership Interests - GlaxoSmithKline; Scopus Biopharma
Honoraria - Scopus BioPharma
Consulting or Advisory Role - Duet Biotherapeutics; Scopus BioPharma
Research Funding - Duet Biotherapeutics
Patents, Royalties, Other Intellectual Property - Patent royalties from Systems Oncology for the patent on T cell targeting RNA aptamer-siRNA conjugate; Royalties for CpG-STAT3 inhibitor patents from Scopus Biopharma
Travel, Accommodations, Expenses - Scopus Biopharma
 
Patrick Pirrotte
No Relationships to Disclose
 
Sumanta Kumar Pal
Travel, Accommodations, Expenses - crispr therapeutics; Roche